These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 10923578)

  • 1. Can we reduce the use of echocardiography by using other clinical information to identify patients at very low risk for left ventricular systolic dysfunction?
    Richardson CR
    J Fam Pract; 2000 Jul; 49(7):655-6. PubMed ID: 10923578
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for left ventricular systolic dysfunction in high-risk patients in primary-care: a cost-benefit analysis.
    Goode KM; Clark AL; Bristow JA; Sykes KB; Cleland JG
    Eur J Heart Fail; 2007 Dec; 9(12):1186-95. PubMed ID: 18006378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart rate recovery immediately after treadmill exercise and left ventricular systolic dysfunction as predictors of mortality: the case of stress echocardiography.
    Watanabe J; Thamilarasan M; Blackstone EH; Thomas JD; Lauer MS
    Circulation; 2001 Oct; 104(16):1911-6. PubMed ID: 11602493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrocardiograph and chest X-ray in prediction of left ventricular systolic dysfunction.
    Basnet BK; Manandhar K; Shrestha R; Shrestha S; Thapa M
    JNMA J Nepal Med Assoc; 2009; 48(176):310-3. PubMed ID: 21105556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demasking of subclinical left ventricular dysfunction in anemic children.
    Kapoor RK; Singh L; Mehrotra S; Mishra PK; Chandra M
    Indian Pediatr; 1999 Oct; 36(10):991-8. PubMed ID: 10745309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical criteria and biochemical markers for the detection of systolic dysfunction.
    Yamamoto K; Burnett JC; Bermudez EA; Jougasaki M; Bailey KR; Redfield MM
    J Card Fail; 2000 Sep; 6(3):194-200. PubMed ID: 10997744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Left cardiac dysfunction in COPD].
    Ciobanu L; Cozma CD; Turcanu D
    Pneumologia; 2004; 53(4):155-60. PubMed ID: 16106722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population.
    Talwar S; Squire IB; Davies JE; Barnett DB; Ng LL
    Eur Heart J; 1999 Dec; 20(23):1736-44. PubMed ID: 10562482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients.
    Romano S; Necozione S; Guarracini L; Fratini S; Cisternino P; di Orio F; Penco M
    J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):238-44. PubMed ID: 19262210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of ECGs in identifying heart failure due to left ventricular systolic dysfunction. Echocardiography is still necessary.
    Khandekar S; Murphy JJ; Bossingham CM
    BMJ; 1996 May; 312(7039):1160. PubMed ID: 8620156
    [No Abstract]   [Full Text] [Related]  

  • 11. Diminished contractile reserve in patients with left ventricular hypertrophy and increased end-systolic stress during Dobutamine stress echocardiography.
    Fontanet HL; Pérez JE; Dávila-Román VG
    Am J Cardiol; 1996 Nov; 78(9):1029-35. PubMed ID: 8916483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction.
    Williams MJ; Odabashian J; Lauer MS; Thomas JD; Marwick TH
    J Am Coll Cardiol; 1996 Jan; 27(1):132-9. PubMed ID: 8522686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systolic and diastolic left ventricular function in patients with dilated cardiomyopathy].
    Sisakian AS
    Klin Med (Mosk); 1997; 75(1):22-3. PubMed ID: 9082051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Practical assessment using transmitral Doppler echocardiography for the evaluation of left ventricular filling pressure in patients with systolic ventricular dysfunction].
    Weihs W; Anelli-Monti B; Schuchlenz H; Harb S
    Acta Med Austriaca; 1999; 26(1):8-11. PubMed ID: 10230469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis of left ventricular dysfunction].
    Cohen A
    Rev Prat; 2001 Sep; 51(14):1513-6. PubMed ID: 11757264
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of systolic and diastolic left ventricular function by echocardiography].
    Haertel JC
    Arq Bras Cardiol; 1995 Apr; 64(4):391-400. PubMed ID: 7495402
    [No Abstract]   [Full Text] [Related]  

  • 17. [Screening for asymptomatic left ventricular systolic dysfunction in high-risk patients. Preliminary experience with a program based on the use of ECG and natriuretic peptide].
    Tarantini L; Cioffi G; Di Lenarda A; Valle R; Pulignano G; Del Sindaco D; Frigo G; Soravia G; Tessier R; Catania G
    G Ital Cardiol (Rome); 2008 Dec; 9(12):835-43. PubMed ID: 19119693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated left ventricular filling pressure during angina.
    Panduranga P; Al-Mukhaini M; Khan A; Kazmi Z; Shahzad S
    J Coll Physicians Surg Pak; 2011 Jul; 21(7):444. PubMed ID: 21777540
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of suspected left ventricular systolic dysfunction.
    Mair FS; Lloyd-Williams F
    J Fam Pract; 2002 May; 51(5):466-71. PubMed ID: 12019059
    [No Abstract]   [Full Text] [Related]  

  • 20. [Screening of asymptomatic left ventricular systolic dysfunction in a population sample at high cardiovascular risk in Lombardy (Italy): the DAVID-Berg study].
    Gavazzi A; De Maria R; Grosu A; Iacovoni A; Fontana A; Gori M; Ferrari P; Canova P; Calabrese A; Filippi A; Rutili MR; Donzelli L; Parolini M; Senni M
    G Ital Cardiol (Rome); 2014 May; 15(5):313-22. PubMed ID: 25002172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.